Class information for:
Level 1: ATTENTION DEFICIT HYPERACTIVITY DISORDER//METHYLPHENIDATE//ADHD

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
743 3033 41.4 59%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
983 10088 ADHD//ATTENTION DEFICIT HYPERACTIVITY DISORDER//JOURNAL OF ATTENTION DISORDERS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ATTENTION DEFICIT HYPERACTIVITY DISORDER Author keyword 104 16% 20% 596
2 METHYLPHENIDATE Author keyword 86 21% 12% 358
3 ADHD Author keyword 63 11% 19% 562
4 ATOMOXETINE Author keyword 58 34% 5% 140
5 JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY Journal 30 16% 6% 176
6 STIMULANT MEDICATION Author keyword 29 45% 2% 48
7 ADDERALL XR Author keyword 23 100% 0% 10
8 LISDEXAMFETAMINE DIMESYLATE Author keyword 22 57% 1% 26
9 STIMULANTS Author keyword 18 16% 3% 104
10 STIMULANT TREATMENT Author keyword 15 71% 0% 12

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ATTENTION DEFICIT HYPERACTIVITY DISORDER 104 16% 20% 596 Search ATTENTION+DEFICIT+HYPERACTIVITY+DISORDER Search ATTENTION+DEFICIT+HYPERACTIVITY+DISORDER
2 METHYLPHENIDATE 86 21% 12% 358 Search METHYLPHENIDATE Search METHYLPHENIDATE
3 ADHD 63 11% 19% 562 Search ADHD Search ADHD
4 ATOMOXETINE 58 34% 5% 140 Search ATOMOXETINE Search ATOMOXETINE
5 STIMULANT MEDICATION 29 45% 2% 48 Search STIMULANT+MEDICATION Search STIMULANT+MEDICATION
6 ADDERALL XR 23 100% 0% 10 Search ADDERALL+XR Search ADDERALL+XR
7 LISDEXAMFETAMINE DIMESYLATE 22 57% 1% 26 Search LISDEXAMFETAMINE+DIMESYLATE Search LISDEXAMFETAMINE+DIMESYLATE
8 STIMULANTS 18 16% 3% 104 Search STIMULANTS Search STIMULANTS
9 STIMULANT TREATMENT 15 71% 0% 12 Search STIMULANT+TREATMENT Search STIMULANT+TREATMENT
10 ADDERALL R 15 88% 0% 7 Search ADDERALL+R Search ADDERALL+R

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 DEFICIT HYPERACTIVITY DISORDER 190 11% 53% 1596
2 METHYLPHENIDATE 148 22% 20% 593
3 STIMULANT MEDICATION 134 49% 7% 201
4 ADHD 124 15% 25% 766
5 STANDARD METHYLPHENIDATE 123 92% 2% 48
6 MULTIMODAL TREATMENT 78 45% 4% 132
7 ONCE A DAY 64 60% 2% 70
8 STIMULANT TREATMENT 63 55% 3% 78
9 SUSTAINED RELEASE METHYLPHENIDATE 61 88% 1% 29
10 ONCE DAILY ATOMOXETINE 48 63% 2% 48

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY 30 16% 6% 176
2 JOURNAL OF ATTENTION DISORDERS 8 12% 2% 64

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder 2008 210 116 65%
The Efficacy of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Clinical Research 2015 2 133 66%
Alpha-2 Agonists for Attention-Deficit/ Hyperactivily Disorder in Youth: A Systematic Review and Meta-Analysis of Monotherapy and Add-On Trials to Stimulant Therapy 2014 16 63 60%
Attention-deficit hyperactivity disorder 2005 732 150 25%
Toward Quality Care in ADHD: Defining the Goals of Treatment 2015 2 158 53%
Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion 2015 1 46 91%
Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009-2011: Focus on clinical efficacy and safety 2014 10 38 76%
A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder 2009 103 110 65%
The Pharmacological Management of Oppositional Behaviour, Conduct Problems, and Aggression in Children and Adolescents With Attention-Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, and Conduct Disorder: A Systematic Review and Meta-Analysis. Part 1: Psychostimulants, Alpha-2 Agonists, and Atomoxetine 2015 1 26 77%
Practitioner Review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents 2013 37 81 44%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 REFERENCE ORPHAN DIS NARCOLEPSY IDIOPATH 9 83% 0.2% 5
2 ADVANCEMENT CHILDRENS MENTAL HLTH 8 45% 0.4% 13
3 ATTENT DEFICIT DISORDER PROGRAM 6 71% 0.2% 5
4 PEDIAT PSYCHOPHARMACOL UNIT 5 14% 1.2% 35
5 CHILD ADOLESCENT TREATMENT PREVENT INTERVENT 4 33% 0.3% 9
6 ATTENT DEFICIT DISORDERS 3 100% 0.1% 3
7 UNIV HLTH IUNICS 3 100% 0.1% 3
8 ADHD 3 30% 0.3% 8
9 UNIT PEDIAT PSYCHOPHARMACOL 3 60% 0.1% 3
10 ADOLESCENT FAMILY MENTAL HLTH SERV 2 67% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000256664 ADULT ADHD//ADHD//JOURNAL OF ATTENTION DISORDERS
2 0.0000254217 SLUGGISH COGNITIVE TEMPO//POSITIVE ILLUSORY BIAS//OPPOSITIONAL DEFIANT DISORDER
3 0.0000210990 RITALIN//METHYLPHENIDATE//METHYLPHENIDATE RITALIN
4 0.0000124053 POST PROGRAM PSYCHIAT MENTAL HLTH//ATTENT DEFICIT STUDY GRP GEDA//GRP OBES EATING DISORDERS GOTA
5 0.0000119697 ACCELERATED RESPONSE//BODILY SENSATION//CARE TEAM
6 0.0000117728 ADHD//ATTENTION DEFICIT HYPERACTIVITY DISORDER//DELAY AVERSION
7 0.0000106007 ATOMOXETINE HYDROCHLORIDE//4 HYDROXYATOMOXETINE//ANTI DEPRESSANT DRUG
8 0.0000103260 JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY//CHRISTIAN SARKINE AUTISM TREATMENT//NISONGER
9 0.0000067475 PRESCRIPTION STIMULANTS//NONMEDICAL USE//MORAL ENHANCEMENT
10 0.0000066388 FEINGOLD DIET//ARTIFICIAL FOOD DYES//ARTIFICIAL FOOD COLORS